Oncozenge Lands SEK2 Million Bridge Loan

MT Newswires · 3d ago
06:28 AM EDT, 08/28/2026 (MT Newswires) -- Clinical-stage pharmaceutical company Oncozenge (ONCOZ.ST) entered into a 2 million-krona bridge financing deal with John Haurum ahead of its planned 33.3 million-krona rights issue. The loan has an arrangement fee of 5% and interest of 1.5% per month, according to a Friday release. The lender may also request that the outstanding loan amount, including accrued interest, be converted into new shares through a directed share issue.